The Contribution of 18F FDG PET-CT for the Investigation of Fever of Unknown Origin and Inflammation of Unknown Origin

Am J Med. 2024 Jul;137(7):629-639. doi: 10.1016/j.amjmed.2024.03.017. Epub 2024 Mar 16.

Abstract

Background: Fever of unknown origin and inflammation of unknown origin are highly challenging diagnostic conditions. The current practice for evaluating patients is to conduct a positron emission tomography-computed tomography (PET-CT) scan as either a first- or a second-line modality. We aimed to assess the contributory effect of PET-CT to the diagnosis and compare it with the contributory effect of CT alone.

Methods: We performed a systematic review and meta-analysis. We included all cohorts that examined the contribution of PET-CT to the investigation of classical fever of unknown origin and inflammation of unknown origin. The primary outcome was the contribution of PET-CT to the final diagnosis. Secondary outcomes were sensitivity and specificity of PET-CT and CT scans, and contribution of a CT scan. We pooled the results of all studies and calculated the pooled contributory effect of PET-CT.

Result: Thirty-six studies (3516 patients) were included in the systematic review. The pooled contribution of PET-CT was 75.4%. The compiled sensitivity and specificity values for all studies were 85.9% and 59.5%, respectively. Five studies (405 patients) compared between the PET-CT component and the total body CT component. The pooled contribution of a CT scan was 68%. The summed sensitivity and specificity values of a CT scan for all studies were 63.1% and 84.4%, respectively.

Conclusions: PET-CT has a contributory effect of 75% for the diagnosis of fever of unknown origin and inflammation of unknown origin. PET-CT had superior sensitivity and inferior specificity vs the CT scan.

Keywords: FUO; Fever of unknown origin; IUO; PET-CT; inflammation of unknown origin.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • Fever of Unknown Origin* / diagnostic imaging
  • Fever of Unknown Origin* / etiology
  • Fluorodeoxyglucose F18*
  • Humans
  • Inflammation* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography* / methods
  • Radiopharmaceuticals*
  • Sensitivity and Specificity*

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals